CTRI/2020/09/027574已完成未知
Safety In-Use Study to Assess the Cutaneous Tolerance of Baby Diaper Rash Cream in Healthy Babies of 0 to 36 Months of Age
Azafran Innovacion ltd0 个研究点目标入组 38 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Babies in the age group of 0 to 36 months inclusive of both genders at the time of consent
- •2 Babies mother or legal representative preferably mother willing to give a voluntary written parental informed consent and agree to come for regular follow up.
- •3 APGAR score greater than 7 at 1 and 5 minutes with no resuscitation required at birth for babies of 0 to 7 days.
- •4 Babies general in good health as determined from a recent medical history.
- •5 Parent or guardian willing to use only the test product in the diaper area during the trial.
- •6 Parent or guardian willing to ensure that their child continues to wear their usual brand of diapers and will continue to clean their child during diaper changes using their usual products and method with the exception of ointments lotions creams or powders during the trial
- •7 Parent or guardian is willing to refrain from changing any other products whose use may have an effect on their child skin condition during the trial ie laundry detergents fabric softeners and products used to bathe the child.
- •8 Wear diapers 24 hours per day.
- •9 Present to the test facility for enrollment at baseline with diaper rash receiving an Overall Severity Score greater than or equal to 1.5 as determined by the trained evaluator.
- •10 Babies with mild to moderate rashes on buttocks and or thigh area assessed by Dermatologist or Dermatologist Validated Scorer using scoring scale will be included in the study.
- •11 Babies mother or legal representative preferably mother willing to abide by and comply with the study protocol.
- •12 Babies should not participate in any other clinical study during participation in the current study.
排除标准
- •1.Babiesâ?? mother/ legal caretaker not willing to stop the use of other baby body milk /lotion / diaper rash cream or any other baby body moisturizing product during the study period.
- •2.Chronic illness which may influence the cutaneous state.
- •3.Babies on any systemic medication.
- •4.Babies currently being toilet trained.
- •5.Babies participating in a similar clinical study, currently or during the previous 30 days.
- •6.Any baby, in the Investigators opinion not considered suitable for enrollment.
- •7.A known history or present condition of allergic response to any other concern that may require medical attention.
- •8.Babies with medical history (past | present) of significant dermatological diseases or conditions, such as atopy, eczema, psoriasis, vitiligo or other conditions known to alter skin appearance or physiologic response (e.g. porphyria) chronic urticaria, or sunburn, rashes
研究者
相似试验
已完成
不适用
Baby Soap study in healthy babiesCTRI/2020/08/027380Azafran Innovacion Limited38
已完成
不适用
Safety study of baby creamCTRI/2020/08/026966Azafran Innovacion Limited38
已完成
不适用
Safety in Use StudyCTRI/2020/09/027540Azafran Innovacion ltd38
已完成
不适用
Safety in Use Study.CTRI/2020/08/027020Azafran Innovacion ltd38
已完成
不适用
Safety assessment of product on skiCTRI/2019/07/019999The Procter Gamble Company120